Rivastigmine Tartrate

Product NDC: 63739-578
11-digit product format: 637390578
Labeler code: 63739
Product ID: 63739-578_b95a67d2-99f6-4b82-e053-2995a90a67a2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Rivastigmine Tartrate
Dosage form: CAPSULE
Route: ORAL
Labeler: McKesson Corporation dba SKY Packaging
Application: ANDA077129
Marketing category: ANDA
Marketing start: 2010-07-01
Marketing end: 0000-00-00
Substance: RIVASTIGMINE TARTRATE
Active strength: 5 mg/1
Pharmacologic classes: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63739-578-10	2020-07-22	C162847	48780-1	ab0e2407-2d5a-f274-e053-dbdaa90a6471	8dc97a13-c5eb-4421-ae86-7e0877186e2d

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63739-578-10	EA - Each	63739-578	7e15b9d8-c837-4388-b08c-5c4b72a260b7	1	2013-03-03

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9IY2357JPE	RIVASTIGMINE TARTRATE	129101-54-8	RIVASTIGMINE TARTRATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63739-578-10	63739057810	10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-578-10) > 10 CAPSULE in 1 BLISTER PACK	10 blister pack	2010-07-01	0000-00-00	No	No	Current